CClinicalTrials.gg
Sign In
CompletedNCT00822822Updated Nov 25, 2013

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

An observational study in Cancer, Cancer Screening Patients and Patient Volunteers, sponsored by H. Lee Moffitt Cancer Center and Research Institute. Completed at 1 site in United States. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-11-25.

Sponsored by H. Lee Moffitt Cancer Center and Research Institute · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
17
Ages
30 Years and older
Sex
All
01

Study summary

The purpose of this research study is to find out what Moffitt and Lifetime patients think of the electronic medical records process.

Read the detailed description

Patient will complete a questionnaire about their knowledge of computers and how long they think it will take them to finish the patient health history using a computer.

Patient will complete the electronic record carefully and tell us if they had any difficulties, questions or comments about the format.

Patient will answer a questionnaire about how well they liked or did not like using the electronic system to give their health history.

Participation in this study will take approximately 30 minutes to 1 hour.

02

Conditions studied

  • Cancer
  • Cancer Screening Patients
  • Patient Volunteers

Keywords

  • Questionnaire
  • Electronic Health History
03

In context

Lead sponsor

H. Lee Moffitt Cancer Center and Research Institute is the lead sponsor of 533 studies on the registry; 74 are open to participants now.

Of its 99 completed or terminated interventional studies of FDA-regulated products, 57 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

People receiving services at Moffitt Cancer Center or Lifetime Cancer Screening Center

Inclusion criteria

  • The breakdown of patients recruited by stratified dimensional sampling. Overall, we will attempt to equally recruit patients from the unique strata for each domain evaluation in this study. Patients health status will be determined by the ECOG Performance status . We assume that all patients being seen at the Lifetime Cancer Screening and Prevention center will be of good to fair health, while patients seen at the Cancer hospital will range from good- to- fair to poor health status. Gender is also used as a sampling factor because there are modules within this web-based health history forms that are specific for each gender.

Exclusion criteria

Exclusion Criteria:

  • Respondents who refuse to participate or who become too ill at any point in the assessment, will be excluded. Non-English speaking patients will be excluded. Names and other identifying information will not be collected and all data will be reported in aggregate form. Due to the nature of our stratified samples strategy, some patients will be excluded if they meet the criteria for a recruitment stata, but that stata is full.
05

Study design

Time perspective
Prospective
Enrollment
17 participants (actual)

Groups and cohorts

  • A

    Health History Process

    Behavioral: First Questionnaire · Behavioral: Health History · Behavioral: Second Questionnaire

Interventions

  • BehavioralFirst Questionnaire

    Complete questionnaire before completing health history

  • BehavioralHealth History

    Complete electronic health history

  • BehavioralSecond Questionnaire

    Complete questionnaire after completing electronic health history

06

What researchers measure

Primary outcomes

  1. Create a system for collecting patient health histories that may be beneficial to patients and people receiving services at Moffitt Cancer Center or Lifetime Cancer Screening Center

    Time frame: 1 hour per participant

07

Study locations

1 site
  • H. Lee Moffitt Cancer Center & Research Institute
    Tampa, Florida 33612, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00822822
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Responsible party
Sponsor
First posted
Jan 14, 2009
Start date
Mar 2006
Primary completion
Nov 2009
Completion
Nov 2009
Last update
Nov 25, 2013

Study contacts

Erin Siegel, Ph.D.
principal investigator · H. Lee Moffitt Cancer Center and Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

H. Lee Moffitt Cancer Center and Research Institute

Start the discussion